Related Experiment Video
Updated: Nov 9, 2025

04:43
Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
Published on: May 23, 2025
478
Successful treatment of Brunsting-Perry pemphigoid with dupilumab
Franklin R Blum1, Justin R Sigmon2
1University of North Carolina Chapel Hill School of Medicine, Chapel Hill, North Carolina.
JAAD Case Reports
|April 14, 2021
Abstract
No abstract available in PubMed .
Keywords:
BPP, Brunsting-Perry pemphigoidBrunsting-Perry pemphigoidFDA, Food and Drug AdministrationIL-13, interleukin 13IL-4, interleukin 4cicatricial pemphigoiddupilumab
